Home / Somatostatin / Germany
DE ATC H01CB01 · updated 2 Nov 2026
Somatostatin shortage in Germany
Is there a Somatostatin shortage in Germany?
Yes. As of 2 Nov 2026, 2 Somatostatin products are reported short in Germany, the first since 9 Dec 2022. The company estimate for the return is 31 Dec 2026. Main reason: manufacturing problem.
Also short in Belgium. All countries.
Affected products in Germany
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Somatostatin 3 mg Inresa | Inresa Arzneimittel GmbH | 9 Dec 2022 | 31 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
| DE | Somatostatin 3 mg Inresa | Inresa Arzneimittel GmbH | 9 Dec 2022 | 31 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
Source
BfArM (Federal Institute for Drugs and Medical Devices), via PharmNet.Bund. Official list. Supply-relevant medicines reported under a voluntary self-commitment; mostly hospital-relevant products.